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Abstract
The United Nations Environment Programme (UNEP/WHO) defines particu-
late matter (PM) as a mixture of solid or liquid particles suspended and dispersed 
in the air. Constituted by a complex mixture of organic and inorganic components 
like metals, acids, soil, and dust is considered a major human carcinogen present 
in air pollution. When inhaled, PM particles penetrate the respiratory tract, where 
they affect different organs and systems depending on their aerodynamic size and 
chemical properties. In the organism, this cocktail-like mixture can interact with 
cellular mechanisms related to the production of reactive oxygen species (ROS) and 
can cause damage to important macromolecules such as DNA, lipids, and proteins. 
Additionally, PM induces a variety of effects at a cellular level, such as inflam-
mation, DNA damage, and genomic instability, acting as a driving force of carci-
nogenic processes and increasing the incidence of respiratory, cardiopulmonary, 
neurogenerative, and neurodevelopment disorders. This book chapter reviews the 
main characteristics of PM, its effects on health, and its role in genomic instability 
and associated molecular mechanisms. Additionally, we explore different biomark-
ers associated with PM exposure, DNA damage, and the influence of PM-related 
oxidative stress in disease development.
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1. Introduction
Air pollution represents a worldwide problem with a significant impact on eco-
systems and human health. According to the World Health Organization (WHO), 
air pollution poses the main environmental risk to health [1]. According to the 
International Agency for Research on Cancer (IARC), exposure to particulate matter 
(PM) in air pollution is considered as a human carcinogen [2]. PM is constituted by 
a heterogeneous mixture of a large variety of small particles of solids and liquids of 
both organic and inorganic nature, derived from natural and anthropogenic sources. 
PM size is an important factor that influences how it is deposited in the respiratory 
tract and affects human health. Large particles are generally filtered in the nose 
and throat and do not necessarily cause problems. An important fraction of PM is 
referred to as PM10, composed of particles ≤10 μm. PM10 is generally subdivided into 
a fraction of finer particles ≤2.5 μm (PM2.5) and a coarser fraction of particles >2.5 
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and <10 μm (PM2.5–10). PM2.5 is dominated by products of combustion and secondary 
particles, while PM2.5–10 consists mainly of crustal, biological, and fine particle frac-
tion components [3]. Thus, smaller PM particles can penetrate deeply in the lungs, 
activating molecular mechanisms of epithelial and defense cells [4].
Exposure to PM, especially around industrial zones and mining systems, has 
been associated with an increase in the morbidity of respiratory diseases, certain 
types of allergies, cardiopulmonary diseases, neurological disorders, and some 
types of cancer [5]. The biological mechanisms behind these associations are not 
entirely known, but the results of toxicological studies in vitro and in vivo have 
shown that PM induces several adverse cellular effects due to the synergistic genera-
tion of reactive oxygen species (ROS), which includes genotoxicity, mutagenicity, 
oxidative stress, inflammation, and increased DNA damage potentially associated 
with genomic instability [6].
Genomic instability is defined as a cell’s increased likelihood to develop and 
accumulate genome alterations (mutations, chromosomal alterations, epigenetic/
posttranscriptional modifications, and changes in gene expression). The frequency 
of these alterations is related to the loss of fidelity in mechanisms such as DNA 
replication, chromosomal segregation, DNA repair, and cell cycle progression 
[7]. These alterations are capable of acting as a driving force of the carcinogenic 
process, a reason why PM exposures are associated with an increase in cancer risk 
[6]. This cancer risk can be evaluated through measurable changes (biochemical, 
physiological, or morphological) that associate with toxic exposure or any early 
biochemical alteration. The identification of these genome damage biomarkers is 
useful by defining a pathogenesis state, such as cancer. It is also of vital importance 
for disease prevention [8]. Consequently, the toxicological investigation of complex 
mixtures such as PM is one of the main objectives of recent research in toxicology 
and cancer [9]. In order to elucidate how genomic background and PM exposure 
can interact, this book chapter focuses on reviewing relevant information based on 
the three main aspects: (I) the characteristics of PM as an environmental pollutant and 
its effects on health, (II) the molecular mechanisms of the cellular effects associated with 
genomic instability by PM exposure, and (III) the use of different risk biomarkers based 
on the determination of chromosomal instability for estimation of cancer risk in popula-
tions exposed to PM.
2. Environmental air pollution, PM, and health effects
Environmental air pollution is defined as the presence in the atmosphere of 
contaminating elements that alter its composition and that affect any component of 
the ecosystem [10]. Air pollution is constituted by an extremely complex mixture that 
includes inorganic components (sulfates, nitrates, ammonium, chloride, and trace 
metals), elemental and organic carbon, biological components (bacteria, spores, 
and pollens), and adsorbed volatile and semi-volatile organic compounds. Besides, 
environmental particles, when mixed with atmospheric gases (ozone, sulfur nitric 
oxides, and carbon monoxide) can generate environmental aerosols or PM [11].
PM is a complex mixture of solid and liquid particles of different origin, size, 
shape, and chemical composition [12]. Atmospheric PM comes from a variety of 
emission sources, including natural and anthropogenic sources. In addition, the 
particulate material can be emitted directly into the atmosphere (primary particles) 
or formed in the atmosphere from gaseous precursors (secondary particles) [13]. 
Among the emission sources, industries are considered one of the most significant 
anthropogenic sources of trace metals [14, 15] although traffic emissions could also 
be regarded as an important source of PM and metals in urban atmospheres [16, 17].
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The size of the PM is of great interest to understand their mobility and their 
impact on health. The respiratory system is the primary intake route of PM in the 
body, and the deposition of particles in different parts of the human body depends 
on the size, shape, and density of the particles, as well as on the individual’s breath-
ing (nasal or oral) [10]. Such health effects induced in the organism depend on the 
granulometry, morphology, time of exposure, individual susceptibility, and finally 
the chemical composition of the particles [18]. In terms of size, PM is categorized 
according to aerodynamic size and is divided into three main groups: the first group is 
large particles, which are generally filtered in the nose and throat and do not neces-
sarily cause problems. The second group is PM10, an essential fraction of PM mostly 
produced by mechanical processes and with sizes between 2.5 and 10 micrometers 
(μm). PM10 is also called “coarse fraction” or “breathable fraction” because of its abil-
ity to enter the respiratory tract [19]. Finally, the third group is PM2.5 or “fine fraction” 
whose aerodynamic diameter is ≤2.5 μm. PM2.5 is mainly derived from combustion 
sources, such as automobiles, trucks, and other vehicle exhausts, as well as from 
stationary combustion sources [19]. PM2.5 can easily reach the terminal bronchioles 
and alveoli, from where can be phagocytosed by alveolar macrophages and cross the 
capillary-alveolar barrier to be transported to other organs by blood circulation [20].
Recently, “ultrafine” particles have been described with aerodynamic size <0.1 
μm; these particles are generated by photochemical processes and combustion, also 
from various natural and anthropogenic sources, and can go directly from the alveoli 
to the bloodstream [21]. Besides, their smaller size and higher surface/mass ratio may 
allow them to have more bioavailability for bioreactive chemicals in their large sur-
face, allowing greater access to the contact points of the cells, increasing its toxicity.
Chemically, PM mainly comprises ions, reactive gases, salts (sulfates, nitrates), 
organic compounds such as polycyclic and/or inorganic aromatic hydrocarbons 
(PAHs), heavy metals (i.e., Fe, Cu, Mo, V, and those with high toxicity such as Pb, 
Cd, and Ni), and carbon core particle [22] compounds with known genotoxic, muta-
genic, and/or carcinogenic activity. However, the chemical composition of PM varies 
greatly and depends on numerous geographical, meteorological, and source-specific 
variables [11]. PM can absorb and transfer a myriad of pollutants which results in 
its variable composition, so depending on the source and composition of the PM, 
different subsets of components may be found on different fractions. PM10 and PM2.5 
are dominated by mechanically abraded or grinded particles including finely divided 
minerals such as oxides of aluminum silicate, iron, calcium, and potassium [23]. 
PM2.5 comprises the soot-rich fraction and other particles within the atmospheric 
gas phase resulting in subsequent agglomeration of PM and producing inorganic 
ions such as sulfate, nitrate, and ammonia, as well as carbon combustion residues, 
organic aerosols, metals, and other combustion products. Unlike inorganic elements 
that can be present in both PM2.5 and PM10 fractions, PAHs show a strong association 
with the PM2.5 fraction. Several studies have reported that 87–95% of PAHs can be 
found in the PM2.5 fraction [24]. The latter correlation seems to be stronger for the 
heavier and more carcinogenic PAHs with five and six aromatic rings.
Also, coarse and fine fractions differ with ultrafine particles in composition 
regarding various heavy metals and possibly a higher content of compounds with 
redox activity, such as prooxidant PAHs (dibenzo (a,l) pyrene) [25] (Table 1).
Health effects caused by PM exposure are supported by increasingly a growing 
number of scientific evidences. The latter comes from a variety of epidemiological 
studies using both population and occupational approach for assessing PM exposure, 
alongside with toxicological studies and human-controlled exposure experiments. 
Results support the causal relationship between PM and premature death, increased 
morbidity from respiratory diseases [26], lung cancer [27], and cardiopulmonary 
diseases [28]. In fact, several health-related studies indicate a strong association of 
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airborne PM generated around coal mines with adverse impacts such as increased 
cardiovascular disease and other pathologies such as pneumoconiosis, neurogenera-
tive and neurodevelopment disorders, and different types of cancer [21].
Particularly, it has been described that PM10 exposure can cause deterioration of the 
respiratory function in a short term, whereas in the long term, it is associated with the 
development of chronic diseases, cancer, or premature death. On the other hand, PM2.5 
exhibits a strong association with increased risk of respiratory disease, cardiovascular 
disorders, type II diabetes mellitus, and even autism spectrum disorders [29–31]. 
Finally, ultrafine particles may be the most active in terms of the induction of systemic 
effects; in fact, studies describe the role of ultrafine particles in the increased risk of 
cardiac hospitalization due to early myocardial infarction and increased frequency of 
readmissions for patients who have survived myocardial infarction and heart failure, 
which allows to consider PM2.5 as a risk factor for cardiovascular disease [32].
3.  Genomic instability by PM exposure and its relation with 
carcinogenesis
Several studies have examined in different experimental models in vivo and 
in vitro the effects of exposure to coarse, fine, and ultrafine PM. These studies 
Study area Population 
description
Area 
description
Analyzed pollutants Reference
Aracaju, Brazil Urban Metropolitan PM, SO2, and elements (Cu, Fe, 
Mn, Ni, V, and Ti)
[33]
Beijing, China Urban Metropolitan PM (PM2.5), NOx, SO2
, volatile 
organic compounds (HAPs), 
ozone, nitrate
[34, 35]
Guajira, 
Colombia
Ethnical Semi-arid PM (PM10 and PM2.5), 
extractable organic matter 
(apolar and polar fractions), and 
elements (Al, Cl, Cr, Cu, K, Mg, 
Mn, Na, P, S, Si, Ti, and Zn)
[36]
Houston, USA Urban Metropolitan PM2.5, NOx, volatile organic 
compounds (light alkenes), 
ozone, sulfate
[37, 38]
Huelva, Spain Urban Industrial PM (PM10, PM2.5 and PM1), 
phosphate, and As
[2]
Los Angeles, 
USA
Urban Metropolitan PM (PM2.5), NOx, volatile 
organic compounds (HAPs), 
ozone, nitrate
[39, 40]
Urban Metropolitan PM2.5, organic carbon, 
ammonium, nitrate, sulfate, and 
elements (Al, Br, Ca, Cl, Cu, Fe, 
K, Mn, Na, Ni, Pb, Si, V, Zn)
[41, 42]
Mexico City, 
Mexico
Urban Metropolitan PM (PM2.5), NOx, volatile 
organic compounds (alkanes, 
HAPs), ozone, sulfate
[43–45]
Sao Paulo and 
Piracicaiba, 
Brazil
Urban Metropolitan PM (PM10 and PM2.5), 
sulphate, nitrate, ammonium, 
elemental carbon, and 
particulate organic material
[46]
Table 1. 
Particulate matter characterization from several cohort studies worldwide.
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provide biological support to epidemiological studies that show an association 
between acute exposure to PM and health effects. The relationship between disease 
and air pollution is well established, but the molecular mechanism regarding their 
relationship is yet to be fully explored.
The interaction of PM with the cellular plasma membrane and its receptors and 
ion channels may directly trigger a biological response. The most important patho-
physiological mechanism that has been proposed to explain the association of PM 
exposure and occurrence of respiratory infections, cancer, and chronic cardiopul-
monary diseases is oxidative stress through the generation of ROS. ROS are oxygen-
related compounds able to induce changes in cellular redox cycle and therefore 
triggering a series of events in cascade such as inflammation, apoptosis, and oxida-
tive damage to macromolecules such as proteins, lipids, and nucleic acids [33]. Under 
the name of ROS, several species derived from the reduction of molecular oxygen 
(O2) are included, mainly superoxide anion (O
2−), hydrogen peroxide (H2O2), and 
hydroxyl radical (OH−), all of which are highly reactive and capable of causing 
damage in the cell. These reactive species can be generated naturally by exhibiting a 
relevant function in cell biology or by inducing oxidizing agents in the medium [34].
Oxidative stress in the cell is caused by an imbalance between the production of 
ROS and the ability of the system to detoxify them or repair the resulting damage 
[35]. In the lungs, a particular target of PM, oxidative stress initiates the synthesis 
of mediators of pulmonary inflammation in lung epithelial cells triggering the acti-
vation of carcinogenic mechanisms (Figure 1). Inflammatory cells are particularly 
effective in generating most of the ROS. The activation of the redox metabolism of 
inflammatory cells generates a highly oxidative environment within an organ for 
aerobic organisms. ROS-mediated inflammation teams with another type of chemi-
cal species such as reactive nitrogen species (RNS) which also causes oxidative 
damage to cellular components. Many proinflammatory mediators, especially cyto-
kines, chemokines, and prostaglandins, turn on the angiogenesis switches mainly 
Figure 1. 
Main processes and biomarkers associated with genomic instability, inflammation and cancer risk induced by 
particulate matter exposure.
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controlled by vascular endothelial growth factors [36, 37]. The possible mechanisms 
by which inflammation can contribute to carcinogenesis include genomic instabil-
ity, alterations in epigenetic events and subsequent inappropriate gene expression, 
enhanced proliferation of initiated cells, resistance to apoptosis, aggressive tumor 
neovascularization, invasion through the tumor-associated basement membrane, 
angiogenesis, and metastasis [36].
Oxidative damage generated by both ROS and RNS species in DNA is considered 
one of the most harmful effects for the cell since they can produce irreversible 
changes in the genome. Chemical modifications in DNA structure include strand 
breaks, sugar moiety modification, nitrogenous base oxidation, and generation of 
apurinic/apyrimidinic sites (AP sites) [38]. This type of DNA damage can be gener-
ated with frequencies between 104 and 105 DNA mutations per cell/day. This DNA 
damage can also produce several chromosomal alterations such as deletions, inser-
tions, or translocations increasing the toxic spectrum for the cell. Accumulation of 
these genomic alterations may cause dysregulation of cell division, the imbalance 
between cell growth and death, and cancer [18].
The use of biological monitoring procedures, or biomonitoring, through specific 
biomarkers can assess the effects of PM exposure and its possible impact on the organ-
ism. Early biomonitoring allows detection of the first alterations during the non-
malignant phase, including the measurable changes (biochemical, physiological, or 
morphological) that associate a toxic exposure with any early biochemical alteration.
3.1  Molecular mechanisms associate with genomic instability and cancer by 
PM exposure
The International Agency for Research on Cancer (IARC) has classified exposure 
to PM in air pollution as a human carcinogen [2]. The molecular reactions induced 
by the PM exposure are often initiated by reactive PM constituents including metals 
and various PAHs and PAH’s derivatives like nitro-PAHs and various oxo-PAHs 
(quinones). These substances are potent oxidants, either through direct effects on 
proteins, lipids, mitochondrial or nuclear DNA or indirectly through the genera-
tion of free radicals and activation of intracellular oxidant pathways [11, 39]. 
Correspondingly, several studies have shown that other transition metals (Fe, Cu, 
Cr, and V) with catalytic activity during Fenton’s reaction (Fe2+ + H2O2 + H
+ → Fe3+ + 
OH˙ + H2O) generate the highly reactive hydroxyl radical able to induce oxidative 
DNA damage, oxidative stress, and inflammatory responses [11].
Depending on its structure, PAHs show carcinogenic potential. IARC classifies 
these compounds as a human carcinogen (group 1), probably carcinogenic (group 2A), 
possibly carcinogenic (group 2B), and not classified as carcinogenic (group 3). 
Particularly, The HAPs that have angulated structures typically react with adenine resi-
dues and are related to a higher carcinogenic activity compared to those with a linear 
and more condensed structure, which usually react with guanine residues [40].
Many of the biological effects of PAHs, including oxidative stress and DNA 
damage, are believed to be mediated by activation of the aryl hydrocarbon receptor 
(AhR) and subsequent induction metabolism by cytochrome P450 (CYP) enzymes 
[41–43]. The binding of PAH metabolites to DNA and the associated effects that 
occur as a consequence are considered the main mechanisms of mutagenicity and 
carcinogenicity attributed to PAHs. Additionally, it is believed that the formation of 
redox-active quinones is catalyzed by dihydrodiol dehydrogenases, also contribut-
ing to PAH carcinogenesis and tumor promotion [44].
At least three distinct molecular mechanisms have been proposed to explain 
the process of tumor initiation by exposure to PAHs. These models include the for-
mation of (1) diol-epoxide, (2) radical cations, and (3) o-quinones. The metabolism 
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of PAHs into diol-epoxide may lead to the formation of DNA adducts, mainly in 
guanines and adenines, generating mutations in proto-oncogenes and tumor sup-
pressor genes. The radical cation leads to the formation of adducts of DNA, generat-
ing AP sites. Finally, o-quinones can generate ROS and potentially cause mutations 
in TP53 and other tumor suppressor genes and/or proto-oncogenes [45].
On the other hand, oxy- and nitro-PAHs, which consist of oxygen and nitro-
gen derivatives of PAHs, respectively, play an important role in the mutagenicity 
attributed to PM. Studies with Salmonella strains (YG1041) sensitive to this group 
of organic compounds indicated a mutagenic activity for a fraction of nitro-PAHs, 
whereas oxy-PAHs can generate DNA adducts [46].
Besides, transition metal ions with redox potential, which are presented in 
PM (adsorbed at high concentrations inside particle cavities), can contribute to 
ROS overproduction and play an important role in oxidative DNA and protein 
damage [47]. Soluble metals on inhaled particles, such as Fe, Ni, V, Co, Cu, and 
Cr, were associated with increased ROS production, followed by cellular oxida-
tive stress in airway epithelial cells [48]. Studies have identified certain metals 
as responsible for oxidant effects and inflammation in experimental animals, by 
using diverse metal chelators (such as EDTA, which increase the redox reactiv-
ity of some metals) and antioxidants (which scavenge oxygen-free radicals) for 
metal assessment [44].
The different types of particles in PM, their extracts, as well as single obtained 
components, all have demonstrated genotoxic effects in human and animal studies 
both in vivo and in vitro [23]. Several studies have shown that cells may be arrested 
in various parts of the cell cycle [49, 50]. Most often, such effects have been linked 
to DNA damage, and following PM exposure, this DNA damage includes mainly 
DNA single-strand breaks, alkali-labile single-strand DNA breaks, and various 
forms of oxidative DNA damage including oxidized guanines measured as 8-oxo-
7,8-dihydroguanine (8-oxoGua) adducts and lesions detected as formamidopyr-
imidine DNA glycosylase (FPG) sites by the comet assay [51]. Often this type of 
damage is associated with chromosomal damage induction. These biomarkers are 
used to assess genotoxic effects on human populations exposed to complex mixtures 
of chemicals.
3.2  Risk biomarkers based on the determination of genomic instability for 
estimation of cancer risk
Exposure biomarkers reflect human exposure on different routes. Biological 
monitoring of PAHs is restricted because of the few PAHs for which metabolites 
are available as standards. However, this limitation is partially overcome by the 
use of metabolite markers of total exposure to PAHs, such as 1-hydroxypyrene 
(1-OHP) [48, 52]. Several studies have shown that urinary 1-OHP is a useful 
biomarker of both environmental and occupational exposures to PAHs and shows a 
correlation with genotoxic effect biomarkers measured in peripheral blood lym-
phocytes [53, 54].
In addition to these biochemical markers, other cytogenetic biomarkers have 
been suggested for the identification of cancer risk; the most generalized and 
best-characterized biomarker for evaluating the mutagenic effects and possible 
cancer risk in populations exposed to PM is the assessment of micronuclei (MN) 
frequency in vivo. MN is an effect biomarker consisting of small nuclear masses of 
genetic material separate from the main nucleus and arising in the dividing cells. 
They are measured 1/3 to 1/16 of the size of the nucleus and are delimited by a 
nuclear membrane. MNs are derived from chromosomal breaks (clastogenic origin) 
and/or whole chromosomes (aneugenic origin). MN composed of fragments of 
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chromosomes (clastogenic) can result from the direct breaking of the double strand 
of DNA, conversion from single-stranded to double-stranded strand after cell 
replication or inhibition of DNA synthesis. The MN formed by whole chromosomes 
(aneugenic) is mainly caused by defects in the mechanism of chromosomal segrega-
tion, such as deficiencies in the control of cell cycle genes, mitotic spindle faults, 
kinetochore, or other parts of the mitotic apparatus, mechanical rupture, or hypo-
methylation of centromeric DNA [55–58]. For MN assessment the used protocol is 
the cytokinesis-block cytome micronucleus assay (CBMNCyt), whereas for rapid 
chromosomal break evaluation, the micronucleus assay with CREST immunostain-
ing (MNCREST) is often used.
CBMNCyt used in primary cultured cells such as lymphocytes allows measur-
ing not only genotoxicity parameters (solely MN frequency) but also cytokinesis 
defects (binucleate cells) and includes MNBN (MN in binucleated or cytokinesis 
blocked cells), a biomarker of chromosome breakage and/or whole chromosome 
loss; MNMONO (MN in mononucleated cells), a biomarker of chromosomal 
damage induced and expressed in vivo before the start of the CBMN assay 
culture; NPBs (nucleoplasmic bridges), a biomarker of DNA misrepair and/or 
telomere end-fusions; and NBUDs (or “nuclear buds”), a biomarker of elimina-
tion of amplified DNA and/or DNA repair complexes [55]. In addition, the assay 
allows measuring the proliferative potential (basal cells) and various forms of 
cell death (pyknotic, karyolytic, karyorrhexis, and chromatin condensation). So, 
the application of this approach provides information on genotoxic, cytotoxic, 
and cytostatic effects increasing the predictive capacity of the bioassay [59]. 
However, it is worth emphasizing that only the frequency of MN has been associ-
ated with an increased risk of cancer development, neurodegenerative diseases, 
and acceleration of aging [56, 60]. MNMONO frequencies may give an estima-
tion of the genome instability accumulated over many years in stem cells and 
circulating T lymphocytes long before the blood was sampled, whereas MNBN 
cells provide an additional measure of lesions that have accumulated in DNA or 
key proteins [61].
In a study developed by our laboratory, we assessed PM exposure in popula-
tions with residential proximity to open-pit coal mine in Northern Colombia and 
investigated the correlation between chromosomal damage and genetic instability 
evaluated by CBMNcyt in isolated lymphocytes of individuals with residential 
proximity to the coal mining corridor and its relation with measured PM10 and 
PM2,5 levels. Our results revealed a significant increase in MNBN and MNMONO 
cells in individuals with residential proximity to open-pit coal mines. Additionally, 
correlation analysis demonstrated a highly significant association between PM2.5 
levels, MNBN frequencies, and CREST+ micronucleus induction in exposed resi-
dents. These results suggest that PM2.5 fraction generated in coal mining activities 
may induce whole chromosome loss (aneuploidy) preferentially, although there are 
also chromosome breaks. This aneugenic effect may be associated with an oxidative 
stress status inside the cell, potentially capable of causing mitotic arrest (elevated 
MNMONO frequency), centromere damage, kinetochore malfunction, or disrup-
tion of the mitotic spindle [18].
Other types of MN assessment use exfoliated buccal cells isolated from exposed 
individuals. The micronucleus test in oral mucosal cells or buccal MN cytome assay 
(BMCyt) has been widely used in studies of populations exposed environmentally 
or occupationally to genotoxic agents. Previous work from our laboratory demon-
strated MN formation in exfoliated buccal cells of workers occupationally exposed 
to open coal mining residues, which correlated with PM increased levels detected 
by BMCyt assay [62]. This technique is particularly attractive because oral mucosal 
cells can be collected in a minimally invasive manner [63, 64].
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4. Conclusions
Sufficient evidence has been accumulated from epidemiological studies that 
support the fact that a broad spectrum of health outcome variables may come from 
short-term exposure to coarse, fine, and ultrafine PM. This association is consistent 
with experimental evidence that identifies different mechanisms of damage at a 
cellular level: inflammation, oxidative stress, cytotoxicity, alterations of autonomic 
nervous system, and coagulation. In relation to chronic effects on health, studies are 
less numerous, and the evidence is still inconsistent. Previous work suggests that 
PM exerts its genotoxic and carcinogenic effects through the generation of DNA 
damage and chromosomal instability. The biological mechanisms behind these 
associations are not fully understood, but toxicological results in vitro have shown 
that PM induces several types of adverse cellular effects.
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